Novel Low-Flow Technology Has Demonstrated Efficacy in Obstructive Sleep Apnea Patients FRESCA Medical, Inc., a privately held sleep solutions and connected health company, announced that the FDA granted their de novo request to market the CURVE™ Positive Airway Pressure delivery system for the treatment of obstructive sleep apnea (OSA). The […]
Tag: FDA
Patients and Family Members to Meet with FDA to Improve Sleep Apnea Treatment Outcomes
New initiative to describe unmet medical needs & treatment expectations from patient point-of-view On June 8, 2018, for the first time ever, sleep apnea patients and their family members will share perspectives on what it’s like to live with sleep apnea with FDA regulators, drug and medical device developers, and […]
ATS Responds to FDA’s Latest Proposal to Reduce Nicotine Levels in Cigarettes
It is with great interest, and some skepticism, that the ATS views the FDA’s recent proposal to reduce nicotine levels in cigarettes to non-addictive levels. In a perfect world, creating a non-addictive cigarette product might be the “silver bullet” we are looking for to reduce the death and disease caused by tobacco […]






